Moseki Raymond M, Barber Daniel L, Du Bruyn Elsa, Shey Muki, Van der Plas Helen, Wilkinson Robert J, Meintjes Graeme, Riou Catherine
Wellcome Center for Infectious Diseases Research in Africa (CIDRI-Africa), University of Cape Town, Cape Town, South Africa.
Institute of Infectious Disease and Molecular Medicine (IDM), University of Cape Town, Cape Town, South Africa.
Open Forum Infect Dis. 2022 Oct 17;10(1):ofac546. doi: 10.1093/ofid/ofac546. eCollection 2023 Jan.
Tuberculosis-associated immune reconstitution inflammatory syndrome (TB-IRIS) is a frequent complication of cotreatment for TB and human immunodeficiency virus (HIV)-1. We characterized (Mtb)-specific CD4 T-cell phenotype and transcription factor profile associated with the development of TB-IRIS.
We examined the role of CD4 T-cell transcription factors in a murine model of mycobacterial IRIS. In humans, we used a longitudinal study design to compare the magnitude of antiretroviral therapy, activation, transcription factor profile, and cytotoxic potential of Mtb-specific CD4 T cells between TB-IRIS ( = 25) and appropriate non-IRIS control patients ( = 18) using flow cytometry.
In the murine model, CD4 T-cell expression of Eomesodermin (Eomes), but not Tbet, was associated with experimentally induced IRIS. In patients, TB-IRIS onset was associated with the expansion of Mtb-specific IFNγCD4 T cells ( = .039). Patients with TB-IRIS had higher HLA-DR expression ( = .016), but no differences in the expression of T-bet or Eomes were observed. At TB-IRIS onset, EomesTbetMtb-specific IFNγCD4 T cells showed higher expression of granzyme B in patients with TB-IRIS ( = .026).
Although the murine model of complex-IRIS suggests that EomesCD4 T cells underly IRIS, TB-IRIS was not associated with Eomes expression in patients. -specific IFNγCD4 T-cell responses in TB-IRIS patients are differentiated, highly activated, and potentially cytotoxic.
结核病相关免疫重建炎症综合征(TB-IRIS)是结核病与人类免疫缺陷病毒(HIV)-1联合治疗常见的并发症。我们对与TB-IRIS发生相关的结核分枝杆菌(Mtb)特异性CD4 T细胞表型和转录因子谱进行了特征分析。
我们在分枝杆菌IRIS小鼠模型中研究了CD4 T细胞转录因子的作用。在人类研究中,我们采用纵向研究设计,通过流式细胞术比较了TB-IRIS患者(n = 25)和适当的非IRIS对照患者(n = 18)之间抗逆转录病毒治疗的强度、Mtb特异性CD4 T细胞的活化、转录因子谱和细胞毒性潜能。
在小鼠模型中,Eomesodermin(Eomes)而非Tbet的CD4 T细胞表达与实验诱导的IRIS相关。在患者中,TB-IRIS的发病与Mtb特异性IFNγ CD4 T细胞的扩增相关(P = 0.039)。TB-IRIS患者的HLA-DR表达较高(P = 0.016),但未观察到T-bet或Eomes表达的差异。在TB-IRIS发病时,Eomes+Tbet−Mtb特异性IFNγ CD4 T细胞在TB-IRIS患者中显示出更高的颗粒酶B表达(P = 0.026)。
虽然复合IRIS小鼠模型提示Eomes+ CD4 T细胞是IRIS的基础,但在患者中TB-IRIS与Eomes表达无关。TB-IRIS患者的Mtb特异性IFNγ CD4 T细胞反应具有分化、高度活化和潜在细胞毒性的特点。